SERIOUS SIDE EFFECTS REPORTED
LOWEST MOD LEVEL AMONG MONOPHASIC FILLERS
THE 9 PROCESS PROMISES AN EXCELLENT QUALITY
Exquisite • Innovation • Aesthetics
e.p.t.q. Thailand Exclusive Distributor
Media & Video
Let's e.p.t.q.! Meet e.p.t.q!
how to combine syringe with needle correctly
Listen to the voice of e.p.t.q.
Blog & Kx
e.p.t.q. marched in China market
Huadong Ningbo Medicine signed contract worth 459 million USD for dermal filler distribution in China market. The company aimed to obtain license in 2024.
Recieved CE Mark for e.p.t.q. dermal filler with Lidocaine
CE Mark was granted for e.p.t.q. HA dermal filler on January 21st, 2021. The achievement of receiving a CE marking for the Exquisite filler with lidocaine, proved the quality and manufacturing standard of Jetema.
Jetema concluded a supply contract worth $6.3 million dollar in Brazillian market.
e.p.t.q. has been imported and distributed by local business partner in Brazil and central/south america. Brazil is the core market in south america aesthetic market.